Precision CRF; Model Number: 706400;

FDA Device Recall #Z-0463-2026 — Class II — October 1, 2025

Recall Summary

Recall Number Z-0463-2026
Classification Class II — Moderate risk
Date Initiated October 1, 2025
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Philips Medical Systems DMC GmbH
Location Hamburg
Product Type Devices
Quantity 42 units

Product Description

Precision CRF; Model Number: 706400;

Reason for Recall

Philips has identified that some ceiling suspension telescopic carriages manufactured from July 2024 through June 2025 may be difficult to move vertically (i.e. additional force/physical exertion required for manual movement) due to potential manufacturing issues.

Distribution Pattern

Worldwide Distribution: US (Nationwide) Distribution and OUS (International) countries of: Australia, Austria, Bahrain, Belgium, Bosnia-Herz., Canada, Chile, Croatia, Denmark, Estonia, Finland, France, Germany, Ghana, Gibraltar, Guadeloupe, Indonesia, Iraq, Israel, Italy, Jordan, Kuwait, Kyrgyzstan, Latvia, Lithuania, Netherlands, New Zealand, Norway, Panama, Philippines, Poland, Portugal, R¿union, Samoa, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, T¿rkiye, Turkmenistan, United Kingdom, Utd.Arab.Emir.,

Lot / Code Information

Model Number: 706400; UDI-DI: 00884838110588; Serial Number: 19, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 10001178, 10001179, 10001181, 10001182, 10001184, 10001185, 10001186, 10001187, 10001188, 10001189, 10001190, 10001191, 10001192, 10001193, 10001194, 10001195, 10001196, 10001197, 10001199, 10001200, 10001201, 10001202, 10001203, 10001204, 10001205, 10001206, 10001208, 10001209;

Other Recalls from Philips Medical Systems DMC GmbH

Recall # Classification Product Date
Z-0466-2026 Class II Radiography 7300 C; Model Number: 712037; Oct 1, 2025
Z-0465-2026 Class II DigitalDiagnost C90 (1) High Performance, (2) F... Oct 1, 2025
Z-0461-2026 Class II ProxiDiagnost N90; Model Number: 706110; Oct 1, 2025
Z-0462-2026 Class II CombiDiagnost R90; Model Number: 709031; Oct 1, 2025
Z-0464-2026 Class II DigitalDiagnost 4 (1) High Performance, (2) Fle... Oct 1, 2025

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.